3-Morpholin-4-yl-propionic acid hydrochloride, 95.0%, 5g

(3R,4S)-4-(p-Tolyl)pyrrolidine-3-carboxylic acid hydrochloride, 95%, 1g

n-(2-Aminoethyl)-3-({2-[(2-aminoethyl)carbamoyl]ethyl}({2-[bis({2-[(2-aminoethyl)carbamoyl]ethyl})amino]ethyl})amino)propanamide, 98%, 1g

Bis(4-(naphthalen-2-yl)phenyl)amine, 97%, 25g

4-Chloro-3,5-dimethyl-1-tosyl-1H-indazole, 97.0%, 250mg

Termómetro recto según DIN 12781, -20 a +150 °C, 525 mm, 250 mm

2-Methyl-4H-benzo[1,4]thiazin-3-one, 97.0%, 1g

4-(3-Bromophenyl)-N-(2-chlorophenyl)thiazol-2-amine hydrobromide, 95.0%, 2g

Ethyl 5-(3-methoxyphenyl)-1,3,4-oxadiazole-2-carboxylate, 1g

(S)-1-phenylethanaminium 2-((((3aS,4S,5R,7S,7aS)-octahydro-1H-4,7-methanoinden-5-yl)oxy)carbonyl)benzoate, 97%, 250mg

(S)-1-(6-Amino-9H-purin-9-yl)propan-2-ol, 95.0%, 25g

1H-imidazo[4,5-b]pyridine-6-carbaldehyde, 95+%, 100mg

(S)-3-(4-Fluoro-2-nitrophenoxy)pyrrolidine hydrochloride, 95.0%, 1g